Withdrawal statement
The authors have withdrawn their manuscript owing to because authors want to do further study about period2-mediated downregulation of ERK/MAPK phosphorylation in nasopharyngeal carcinoma. Therefore, the authors do not wish this work to be cited as reference for the project. If you have any questions, please contact the corresponding author.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the Natural Science Foundation of Ningxia Province [grant number 2019AAC03210],Granted by: Hailiang Li Ningxia Medical University [grant number XM20211041],Granted by: Zhijuan Zhang Natural Science Foundation of Ningxia Province [grant number 2019AAC03215],Granted by: Li Hou Key Research and Development Program of Ningxia [grant number 2022BEG03105],Granted by: Li Hou. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the ethics committee of the General Hospital of Ningxia Medical University(Ethics Number: KYLL-2021-1023), and all patients signed written informed consent.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
